Hippocampal Shape Analysis of Alzheimer Disease Based on Machine Learning Methods

References

1. ↵
   Arriagada PV, Growdon JH, Hedley-Whyte ET, et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42:631–39

   Abstract/FREE Full Text
2. Berg L, McKeel DWJ, Miller JP, et al. Clinico-pathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex and apolipoprotein e genotype. Arch Neurology 1998;55:326–35

   CrossRefPubMedWeb of Science
3. ↵
   Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239–59

   CrossRefPubMedWeb of Science
4. ↵
   Squire LR, Zola-Morgan S. The medial temporal lobe memory system. Science 1991;253:1380–86

   Abstract/FREE Full Text
5. ↵
   West MJ, Coleman PD, Flood DG, et al. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 1994;344:769–72

   CrossRefPubMedWeb of Science
6. ↵
   Convit A, DeLeon MJ, Tarshish C, et al. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol Aging 1997;18:131–38

   CrossRefPubMedWeb of Science
7. DeLeon M, Bobinski M, Convit A, et al. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology 2001;56:820–21

   FREE Full Text
8. Dickerson BC, Goncharova I, Sullivan MP, et al. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging 2001;22:747–54

   CrossRefPubMedWeb of Science
9. ↵
   Du AT, Schuff N, Amend D, et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2001;71:441–47

   Abstract/FREE Full Text
10. ↵
    Jack CR Jr, Slomkowski M, Gracon S, et al. MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology 2003;60:253–60

    Abstract/FREE Full Text
11. ↵
    Ashburner J, Friston KJ. Voxel-based morphometry-the methods. Neuroimage 2000;11:805–21

    CrossRefPubMedWeb of Science
12. ↵
    Boxer AL, Rankin KP, Miller BL, et al. Cinguloparietal atrophy distinguishes Alzheimer disease from semantic dementia. Arch Neurol 2003;60:949–56

    CrossRefPubMedWeb of Science
13. ↵
    Busatto GF, Garrido GE, Almeida OP, et al. A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer's disease. Neurobiol Aging 2003;24:221–31

    CrossRefPubMedWeb of Science
14. ↵
    Frisoni GB, Testa C, Zorzan A, et al. Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry. J Neurol Neurosurg Psychiatry 2002;73:657–64

    Abstract/FREE Full Text
15. ↵
    Good CD, Scahill RI, Fox NC, et al. Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. Neuroimage 2002;17:29–46

    CrossRefPubMedWeb of Science
16. ↵
    Karas GB, Burton EJ, Rombouts SA, et al. A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. Neuroimage 2003;18:895–907

    CrossRefPubMedWeb of Science
17. ↵
    Thompson PM, Hayashi KM, De Zubicaray GI, et al. Mapping hippocampal and ventricular change in Alzheimer disease. NeuroImage 2004;22:1754–66

    CrossRefPubMedWeb of Science
18. ↵
    Wang L, Miller JP, Gado MH, et al. Abnormalities of hippocampal surface structure in very mild dementia of the Alzheimer type. Neuroimage 2006;30:52–60

    CrossRefPubMedWeb of Science
19. ↵
    Csernansky JG, Wang L, Miller JP, et al. Neuroanatomical predictors of response to donepezil therapy in patients with dementia. Arch Neurol 2005;62:1718–22

    CrossRefPubMedWeb of Science
20. ↵
    Csernansky JG, Wang L, Joshi S, et al. Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly. NeuroImage 2005;25:783–92

    CrossRefPubMedWeb of Science
21. ↵
    Lao Z, Shen D, Xue Z, et al. Morphological classification of brains via high-dimensional shape transformations and machine learning methods. NeuroImage 2004;21:46–57

    CrossRefPubMedWeb of Science
22. ↵
    Golland P, Grimson WEL, Shenton ME, et al. Deformation analysis for shape based classification. Proc IPMI 2001;2082:517–30
23. ↵
    Yushkevich P, Joshi S, Pizer SM, et al. Feature selection for shape-based classification of biological objects. Proc IPMI 2003;2732:114–25
24. ↵
    McKhann G, Drachman D, Folstern M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services task force on Alzheimer's disease. Neurology 1984;34:939–44

    Abstract/FREE Full Text
25. ↵
    Folstein MF, Folstein SE, McHugh PR. ‘Mini mental state': a practical method of grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98

    CrossRefPubMedWeb of Science
26. ↵
    Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 1998;17:87–97

    CrossRefPubMedWeb of Science
27. ↵
    Duvernoy H. The Human Hippocampus. An Atlas of Applied Anatomy. Munich: JF Bergmann Verlag;1988
28. ↵
    Zhu LT, Jiang TZ. Parameterization of 3D brain structures for statistical shape analysis. Proc SPIE Med Imaging, February 14–19,2004; San Diego, Calif
29. ↵
    Chui HL, Rangarajan A. A new point matching algorithm for non-rigid registration. Comput Vis Image Underst 2003;89:114–41

    CrossRef
30. ↵
    Guyon I, Weston J, Barnhill S, et al. Gene selection for cancer classification using support vector machines. Mach Learn 2002;46:389–422

    CrossRef
31. ↵
    Li FM, Eun SY. Improving reliability of gene selection from microarray functional genomics data. IEEE Trans Inf Technol Biomed 2003;7:191–96

    CrossRefPubMed
32. ↵
    Bobinski M, de Leon MJ, Tarnawski M, et al. Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer disease. Brain Res 1998;805:267–69

    CrossRefPubMedWeb of Science
33. ↵
    Mizukami K, Ikonomovic MD, Grayson DR, et al. Immunohistochemical study of GABAA receptor alpha1 subunit in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes. Brain Res 1998;799:148–55

    CrossRefPubMedWeb of Science
34. Muramori F, Kobayashi K, Nakamura I. A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer's disease, normal controls and non-Alzheimer neuropsychiatric diseases. Psychiatry Clin Neurosci 1998;52:593–99

    CrossRefPubMed
35. Price JL, Morris JC. Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease. Ann Neurol 1999;45:358–68

    CrossRefPubMedWeb of Science
36. ↵
    Sheng JG, Mrak RE, Griffin WS. Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer disease. J Neuropathol Exp Neurol 1998;57:323–28

    PubMedWeb of Science
37. ↵
    Mizutani T, Kasahara M. Degeneration of the intrahippocampal routes of the perforant and alvear pathways in senile dementia of Alzheimer type. Neurosci Lett 1995;184:141–44

    CrossRefPubMedWeb of Science
38. Mizutani T, Kasahara M. Hippocampal atrophy secondary to entorhinal cortical degeneration in Alzheimer-type dementia. Neurosci Lett 1997;222:119–22

    CrossRefPubMedWeb of Science
39. Mizutani T, Shimada H. Neuropathological background of twenty seven centenarian brains. J Neurol Sci 1992;108:168–77

    CrossRefPubMedWeb of Science
40. ↵
    Hyman BT, Van Hoesen GW, Kromer LJ, et al. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol 1986;20:472–81

    CrossRefPubMedWeb of Science
41. ↵
    Testa C, Laakso MP, Sabattoli F, et al. A comparison between the accuracy of voxel-based morphometry and hippocampal volumetry in Alzheimer's disease. J Magn Reson Imaging 2004;19:274–82

    CrossRefPubMedWeb of Science
42. ↵
    Bouix S, Pruessner JC, Louis Collins D, et al. Hippocampal shape analysis using medial surfaces. Neuroimage 2005;25:1077–89

    CrossRefPubMed
43. ↵
    Wang Y, Chiang MC, Thompson PM. Automated surface matching using mutual information applied to Riemann surface structures. Int Conf Med Image Comput Assist Interv 2005;8:666–74
44. ↵
    Laakso MP, Soininen H, Partanen K, et al. Volumes of hippocampus, amygdala and frontal lobes in the MRI based diagnosis of early Alzheimer's disease: correlation with memory functions. J Neural Transm 1995;9:73–86

    CrossRef
45. ↵
    Remy F, Mirrashed F, Campbell B, et al. Verbal episodic memory impairment in Alzheimer's disease: a combined structural and functional MRI study. NeuroImage 2005;25:253–66

    CrossRefPubMedWeb of Science
46. ↵
    Baron JC, Chetelat G, Desgranges B, et al. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. NeuroImage 2001;14:298–309

    CrossRefPubMedWeb of Science
47. ↵
    Thompson PM, Mega MS, Woods RP, et al. Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. Cereb Cortex 2001;11:1–16

    Abstract/FREE Full Text
48. ↵
    Thompson PM, Hayashi KM, de Zubicaray, et al. Dynamics of gray matter loss in normal aging and Alzheimer's disease. J Neurosci 2003;23:994–1005

    Abstract/FREE Full Text
49. ↵
    Johnson KA, Jones K, Holman BL, et al. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 1998;50:1563–71

    Abstract/FREE Full Text
50. ↵
    Duara R, Grady C, Haxby J, et al. Positron emission tomography in Alzheimer's disease. Neurology 1986;36:879–87

    Abstract/FREE Full Text
51. ↵
    Kantarci K, Jack CR Jr. Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease. Neurorx 2004;1:196–205

    Abstract/FREE Full Text